Baidu
map

Blood:该如何治疗疣、低丙种球蛋白血症、感染以及先天性髓系粒细胞缺乏(WHIM)四联症?

2017-10-25 qinqiyun MedSci原创

疣、低丙种球蛋白血症、感染以及先天性髓系粒细胞缺乏(WHIM)四联症是一种常染色体显性遗传病,其特点为中性粒细胞减少、淋巴细胞减少、易感染和髓系粒细胞缺乏,亦被认为是成熟中性粒细胞的退行性变和骨髓细胞增生。

疣、低丙种球蛋白血症、感染以及先天性髓系粒细胞缺乏(WHIM)四联症是一种常染色体显性遗传病,其特点为中性粒细胞减少、淋巴细胞减少、易感染和髓系粒细胞缺乏,亦被认为是成熟中性粒细胞的退行性变和骨髓细胞增生。

大部分患者表现为低丙球蛋白血症和(或)难治性的皮肤及生殖器疣,少数患者表现为先天性心脏缺陷。

该病为常染色体显性遗传,常由趋化因子受体CXCR4杂合突变导致。突变导致中性粒细胞和淋巴细胞对特异性配体CXCL12的敏感性增加,并导致成熟中性粒细胞在骨髓中积累增多。

虽然对此疾病的了解日益加深,但目前尚无改善该病的某些结局的有效治疗方法,如支气管扩张、肛门及生殖器发育异常或侵袭性癌症。

本文主要论述了降低WHIM患者感染风险的有效治疗措施,并严格评估WHIM综合征的诊断标准,特别是当患者表现为先天性中性粒细胞减少和淋巴细胞减少,但没有低丙球蛋白血症和(或)疣的表现时,应高度怀疑是否是WHIM综合征。

最后,作者还对关于普乐沙福(Plerixafor,CXCR4的一种选择性拮抗剂)用于治疗WHIM患者的临床试验的近期结果进行讨论。

原始出处:

Raffaele Badolato and Jean Donadieu. How I treat warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.Blood  2017  :blood-2017-02-708552;  doi: https://doi.org/10.1182/blood-2017-02-708552 .

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2035152, encodeId=b50820351526e, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Fri Jun 08 20:46:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689279, encodeId=803716892e932, content=<a href='/topic/show?id=cffa20922a2' target=_blank style='color:#2F92EE;'>#丙种球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20922, encryptionId=cffa20922a2, topicName=丙种球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a428781144, createdName=ms1490123962508630, createdTime=Wed Dec 27 09:46:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369320, encodeId=85a013693202e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 27 07:46:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255896, encodeId=f8b8255896aa, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Oct 25 16:54:51 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
    2018-06-08 xzw113
  2. [GetPortalCommentsPageByObjectIdResponse(id=2035152, encodeId=b50820351526e, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Fri Jun 08 20:46:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689279, encodeId=803716892e932, content=<a href='/topic/show?id=cffa20922a2' target=_blank style='color:#2F92EE;'>#丙种球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20922, encryptionId=cffa20922a2, topicName=丙种球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a428781144, createdName=ms1490123962508630, createdTime=Wed Dec 27 09:46:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369320, encodeId=85a013693202e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 27 07:46:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255896, encodeId=f8b8255896aa, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Oct 25 16:54:51 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2035152, encodeId=b50820351526e, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Fri Jun 08 20:46:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689279, encodeId=803716892e932, content=<a href='/topic/show?id=cffa20922a2' target=_blank style='color:#2F92EE;'>#丙种球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20922, encryptionId=cffa20922a2, topicName=丙种球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a428781144, createdName=ms1490123962508630, createdTime=Wed Dec 27 09:46:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369320, encodeId=85a013693202e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 27 07:46:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255896, encodeId=f8b8255896aa, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Oct 25 16:54:51 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
    2017-10-27 huirong
  4. [GetPortalCommentsPageByObjectIdResponse(id=2035152, encodeId=b50820351526e, content=<a href='/topic/show?id=5a426866eae' target=_blank style='color:#2F92EE;'>#球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68667, encryptionId=5a426866eae, topicName=球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Fri Jun 08 20:46:00 CST 2018, time=2018-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1689279, encodeId=803716892e932, content=<a href='/topic/show?id=cffa20922a2' target=_blank style='color:#2F92EE;'>#丙种球蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20922, encryptionId=cffa20922a2, topicName=丙种球蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04a428781144, createdName=ms1490123962508630, createdTime=Wed Dec 27 09:46:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369320, encodeId=85a013693202e, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Fri Oct 27 07:46:00 CST 2017, time=2017-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255896, encodeId=f8b8255896aa, content=好文章.学习了., beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Wed Oct 25 16:54:51 CST 2017, time=2017-10-25, status=1, ipAttribution=)]
    2017-10-25 1e0f8808m18(暂无匿称)

    好文章.学习了.

    0

Baidu
map
Baidu
map
Baidu
map